Enwei Pharmaceutical Cash Flow Statement

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022	Dec '20 Dec 31, 2020
Net Income	52.06	37.5	86.31	67.8	101.73	98.74
Depreciation & Amortization	46.13	46.13	34.83	30.91	30.5	32.79
Other Amortization	6.58	6.58	6.55	6.88	5.59	4.56
Loss (Gain) From Sale of Assets	0.26	0.26	0.04	-	-	-
Asset Writedown & Restructuring Costs	5.44	5.44	0.58	1.65	0.07	-0.09
Loss (Gain) From Sale of Investments	-3.49	-3.49	-3.74	-0.59	0.44	-0.01
Other Operating Activities	14.01	23.84	0.35	-1.56	-0.52	6.18
Change in Accounts Receivable	-36.43	-36.43	-9.67	-69.89	30.16	-44.31
Change in Inventory	-12.06	-12.06	-2.9	5.4	-31.39	-7.48
Change in Accounts Payable	12.96	12.96	-27.81	22.12	-50.73	-13.51
Operating Cash Flow	83.66	78.92	84.01	62.35	87.58	78.52
Operating Cash Flow Growth	-20.51%	-6.06%	34.73%	-28.80%	11.53%	-34.40%
Capital Expenditures	-50.77	-50.23	-134.05	-23.56	-38.21	-31.16
Sale of Property, Plant & Equipment	0.29	0.34	0.15	-	-	0.01
Investment in Securities	-1,017	-1,018	-685.5	-221.5	-	-
Other Investing Activities	891.29	957.37	775.22	1.05	0.52	0.32
Investing Cash Flow	-176.55	-110.62	-44.18	-244.01	-37.7	-30.83
Long-Term Debt Issued	-	241.8	-	-	-	-
Long-Term Debt Repaid	-	-48.09	-	-	-	-10
Net Debt Issued (Repaid)	-12.26	193.71	-	-	-	-10
Issuance of Common Stock	18.36	18.36	-	470.75	-	-
Repurchase of Common Stock	-70.01	-70.01	-33	-	-	-
Common Dividends Paid	-21.33	-56.96	-112.22	-	-46	-1.5
Other Financing Activities	72.27	-	-	-12.28	-2.41	-20.41
Financing Cash Flow	-12.97	85.1	-145.22	458.47	-48.41	-31.91
Foreign Exchange Rate Adjustments	0	0	-0.03	0.16	-0.24	-0.17
Net Cash Flow	-105.86	53.41	-105.41	276.98	1.23	15.6
Free Cash Flow	32.89	28.69	-50.04	38.8	49.36	47.36
Free Cash Flow Growth	-	-	-	-21.41%	4.24%	-51.90%
Free Cash Flow Margin	3.70%	3.53%	-6.37%	5.61%	7.26%	7.47%
Free Cash Flow Per Share	0.33	0.28	-0.49	0.46	0.63	0.65
Cash Interest Paid	-	-	-	-	-	0.08
Cash Income Tax Paid	77.01	80.87	84.86	58.93	79.2	70.39
Levered Free Cash Flow	36.09	27.34	-68.83	41.25	21.46	11.86
Unlevered Free Cash Flow	38.09	28.85	-68.83	41.25	21.46	11.89
Change in Working Capital	-37.33	-37.33	-40.9	-42.73	-50.23	-63.64

Source: S&P Global Market Intelligence. Standard template. Financial Sources.